Aimmune Therapeutics, Inc.

Q4 2018 13F Holders

Symbol
AIMT
CUSIP
00900T107
Type
Equity
Class
COM
Num filings
139
Total reported value, excl. options
$1.11 B
Manager Report Date Value ($000) Shares Option Type